The continuing clinical role of gallium 67 scintigraphy in the age of receptor imaging
- 31 January 1997
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 27 (1) , 68-74
- https://doi.org/10.1016/s0001-2998(97)80037-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1996
- The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patientsSeminars in Nuclear Medicine, 1995
- The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapyAnnals of Oncology, 1994
- Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease.Journal of Clinical Oncology, 1994
- Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.Radiology, 1994
- Lymphoma: predictive value of Ga-67 scintigraphy after treatment.Radiology, 1992
- Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma.Journal of Clinical Oncology, 1990
- Ga-67 SPECT before and after treatment of lymphoma.Radiology, 1990
- Gallium 67 imaging in monitoring lymphoma response to treatmentCancer, 1988
- Residual mass in lymphoma may not be residual disease.Journal of Clinical Oncology, 1988